Scarica l'app Stockscreener
16.58
0.00%
0.00
Dopo l'orario di chiusura:
16.60
0.02
+0.12%
Precedente Chiudi:
$16.58
Aprire:
$16.59
Volume 24 ore:
27,470
Relative Volume:
0.28
Capitalizzazione di mercato:
$212.81M
Reddito:
$16.96M
Utile/perdita netta:
$-23.88M
Rapporto P/E:
-7.9065
EPS:
-2.097
Flusso di cassa netto:
$-20.66M
1 W Prestazione:
-2.64%
1M Prestazione:
-4.00%
6M Prestazione:
-7.06%
1 anno Prestazione:
-9.05%
Intervallo 1D:
$16.46
$16.80
Intervallo di 1 settimana:
$16.44
$17.60
Portata 52W:
$14.14
$22.50
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
16.58 | 212.81M | 16.96M | -23.88M | -20.66M | -2.097 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2025-05-02 | Iniziato | Alliance Global Partners | Buy |
| 2025-02-28 | Iniziato | Craig Hallum | Buy |
| 2024-07-16 | Reiterato | Maxim Group | Buy |
| 2022-12-22 | Iniziato | Maxim Group | Buy |
| 2022-07-18 | Ripresa | Oppenheimer | Outperform |
| 2020-09-23 | Iniziato | BTIG Research | Buy |
| 2016-11-28 | Iniziato | Aegis Capital | Buy |
| 2016-08-17 | Iniziato | Wells Fargo | Outperform |
| 2014-04-16 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Mediwound Ltd Borsa (MDWD) Ultime notizie
Medical Maggots Market Hits New High | Major Giants BioMonde, Maggot Therapy, MediWound - openPR.com
Performance Recap: Is MediWound Ltd forming a bullish divergenceDip Buying & AI Optimized Trading Strategy Guides - baoquankhu1.vn
FY2030 Earnings Estimate for MediWound Issued By Maxim Group - Defense World
Institution Moves: Does MediWound Ltd meet Warren Buffetts criteria2026 Earnings Impact & Advanced Swing Trade Entry Plans - baoquankhu1.vn
FY2030 Earnings Forecast for MediWound Issued By Maxim Group - MarketBeat
MediWound Is the Biotech Governments Have Been Stockpiling for E - GuruFocus
MediWound Is the Biotech Governments Have Been Stockpiling for Exactly These Kinds of Wars (NASDAQ: MDWD) - TradingView
MediWound outlines $24M–$26M 2026 revenue target while expanding EscharEx clinical programs - MSN
MediWound (MDWD) Q4 2025 Earnings Call Transcript - AOL.com
MDWD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
MediWound Ltd. (NASDAQ:MDWD) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Behavioral Patterns of MDWD and Institutional Flows - Stock Traders Daily
MediWound (NASDAQ:MDWD) Stock Rating Lowered by Wall Street Zen - MarketBeat
MediWound Ltd. (NASDAQ:MDWD) Q4 2025 Earnings Call Transcript - Insider Monkey
MediWound: Q4 Earnings Snapshot - theheraldreview.com
MediWound Posts 2025 Loss but Strengthens Cash and Advances EscharEx, NexoBrid Capacity - The Globe and Mail
Mediwound earnings beat by $0.03, revenue fell short of estimates - Investing.com Australia
MediWound Q4 Earnings Call Highlights - MarketBeat
MediWound (MDWD) Heavy FY 2025 Losses Test High Growth And Premium P/S Narrative - simplywall.st
MediWound Q4 2025 Earnings Call Transcript - MarketBeat
MediWound Files Annual Report on Form 20-F - Bluefield Daily Telegraph
MediWound Ltd. Q4 2025 Earnings Call Summary - Yahoo Finance
MediWound (NASDAQ:MDWD) Issues Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat
MDWD: Expanded manufacturing, clinical progress, and strong guidance despite 2025 revenue decline - TradingView
MediWound Reports Fourth Quarter and Full Year 2025 Financial Results - Bitget
MediWound (MDWD) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
MDWD Maintains Revenue Forecasts Through 2028 - GuruFocus
MediWound (MDWD) Reports Lower-than-Expected Q4 Revenue - GuruFocus
MediWound: Overview of Fourth Quarter Financial Results - Bitget
MEDIWOUND ($MDWD) Releases Q4 2025 Earnings - Quiver Quantitative
MediWound (NASDAQ: MDWD) posts 2025 loss with cash rising above $53M - Stock Titan
Insights into MediWound Q4 Earnings - Benzinga
MediWound boosts burn drug output sixfold, guides to $24–26M 2026 sales - Stock Titan
MediWound Ltd. recently announced that it has once again confirmed its financial forecast targets for the coming years. - Bitget
What to Expect from MediWound's Earnings - Benzinga
Earnings Preview: MediWound to Report Financial Results Pre-market on March 05 - 富途牛牛
Mediwound Ltd expected to post a loss of 63 cents a shareEarnings Preview - TradingView
MediWound at TD Cowen Conference: Strategic Growth and Market Expansion - Investing.com Nigeria
MediWound Updates NexoBrid Growth, EscharEx Phase III Timeline and BARDA Talks at Oppenheimer Conference - MarketBeat
Clal Insurance Enterprises Holdings Ltd Acquires New Position in MediWound Ltd. $MDWD - MarketBeat
MediWound at Oppenheimer Conference: Strategic Growth and Innovation - Investing.com Australia
MediWound (MDWD) Expected to Announce Earnings on Thursday - MarketBeat
(MDWD) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
MediWound (NASDAQ:MDWD) Share Price Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Will MediWound Ltd. stock benefit from green energy trendsEarnings Summary Report & Safe Swing Trade Setups - mfd.ru
MediWound Shareholders Approve Expansion of 2024 Equity Incentive Pool - The Globe and Mail
MediWound to Report Fourth Quarter and Full Year 2025 Financial Results - Bitget
Will MediWound Ltd. stock outperform international peersJuly 2025 Spike Watch & Fast Entry and Exit Trade Plans - mfd.ru
MediWound Ltd. (NASDAQ:MDWD) Short Interest Up 20.9% in January - MarketBeat
Mediwound Ltd Azioni (MDWD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):